TDACW NASDAQ
Translational Development Acquisition Corp.
1W: -35.2%
1M: -35.2%
3M: -62.9%
YTD: -61.3%
$0.12
+0.02 (+19.78%)
Weekly Expected Move ±98.5%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$2.8M
52W Range0.1101-0.325
Volume374
Avg Volume6,954
Beta2.11
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMichael Hoffman
Employees2
SectorFinancial Services
IndustryShell Companies
IPO Date2025-06-16
52 E. 83rd Street
New York City, DE 10028
US
New York City, DE 10028
US
917 979 3072
About Translational Development Acquisition Corp.
Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Jarratt Christopher | 0 | — | 2024-12-20 | |
| Keith Curtis T | 0 | — | 2024-12-20 | |
| TDAC Partners LLC | 4,657,500 | — | 2024-12-20 | |
| Reddy E Premkumar | 0 | — | 2024-12-20 | |
| Kestenbaum Matthew | 0 | — | 2024-12-20 |